Stanford University Medical Center

Palo Alto, California 94605

27 studies enrolling now · 186 studies all time

What they study most

ALS, Acromegaly, Acute Alcoholic Hepatitis, Acute Ischemic Stroke, Acute Kidney Injury, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Pain, Acute Pancreatic Necrosis, Acute Pancreatitis, Adenoma, Adrenocortical Carcinoma

Studies at this site

• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis — Recruiting now
• Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers — Recruiting now
• Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
• A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose — Recruiting now
• Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children — Recruiting now
• Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs. — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy — Recruiting now
• Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) — Recruiting now
• Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
• J-Valve Transfemoral Pivotal Study — Recruiting now
• Rapid Non-Invasive Brain Stimulation for Hoarding Disorder — Recruiting now
• Avapritinib With Decitabine in Patients With SM-AHN — Recruiting now
• Rapid Evacuation and Access of Cerebral Hemorrhage Trial — Recruiting now
• MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) — Recruiting now
• Platform Clinical Study for Conquering Scleroderma — Recruiting now
• A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. — Recruiting now
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry — Recruiting now
• A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators — Recruiting now
• Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry — Recruiting now
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children — Completed
• Pyruvate Kinase Deficiency Global Longitudinal Registry — Running, not enrolling
• A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Running, not enrolling
• FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) — Running, not enrolling
• Rethinking Early Airway Clearence Therapies — Starting soon
• Personalized Blood Transfusion Protocol for Cardiac Patients — Starting soon
• A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection — Completed
• Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements — Starting soon
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Running, not enrolling
• Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy — Completed
• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — Completed
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
• A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults — Stopped early
• The PROMISE Pediatric Study 6 to 11 Years Old — Completed
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Colorectal Cancer Screening in Cystic Fibrosis — Running, not enrolling
• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy — Completed
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis — Completed
• Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
• A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma — Completed
• A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) — Completed